OR WAIT 15 SECS
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Botulinum toxin injected into the prostate reduced symptoms of benign prostatic hyperplasia (BPH) and prostate-specific antigen (PSA) levels and was well tolerated, according to the results of a randomized, placebo-controlled, preliminary trial (Urology 2003; 62:259-265).